Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - Regen BioPharma Inc | ex99_2.htm |
| 8-K - FORM 8-K - Regen BioPharma Inc | rgbp012220form8k.htm |
Exhibit 99.1
TO: Todd S. Caven
Chief Financial Officer and
Director / Board Member
Regen BioPharma, Inc.
Zander Therapeutics, Inc.
KCL Therapeutics, Inc.
RE: Resignation as officer and director of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
Effective as of 1 pm Pacific Standard Time on January 22, 2020 I resign my positions as Chairman of the Board of Directors, Chief Executive Officer and any and all other offices I may hold of Regen BioPharma Inc., Zander Therapeutics Inc. and KCL Therapeutics Inc.
This leaves you serving as the sole officer and director of the abovementioned three corporations.
I am available to serve as a consultant should you desire. Terms of such service shall be negotiated separately on a case by case basis.
Sincerely,
/s/ David R. Koos
David R. Koos
1/22/2020